Titre Personalized Targeted Therapy in Refractory or Relapsed Cancer in Childhood(TRICEPS Study)
Protocole ID TRICEPS
ClinicalTrials.gov ID NCT02242552
Type(s) de cancer Pédiatrique divers
Phase
Institution CHU DE QUEBEC – UNIVERSITE LAVAL
   CHUL ET CENTRE MERE-ENFANT SOLEIL
      2705 boulevard Laurier, Québec, QC, G1V 4G2
Ville Québec
Investigateur(trice) principal(e) Dr Bruno Michon
Coordonnateur(trice) Barbara Desbiens
 418-525-4444 poste 40195

Marie-Christine Gagnon
 418-525-4444 poste 40196
Statut Actif en recrutement
Critètes d'éligibilité
  • 21 year-old or less
  • Poor prognosis biopsy-proven cancer of any type :
  • Cancer (at initial diagnosis) known to be refractory to treatment
  • Or cancer refractory to treatment
  • Or relapsed cancer
  • Written informed consent by patient, parents, or the legal guardians
Critètes d'exclusion
  • Estimated life expectancy of less than 3 months.